Rafferty Asset Management
CRBU icon

Rafferty Asset Management’s Caribou Biosciences CRBU Stock Holding History

Rafferty Asset Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-541,449
Closed -$2.78M – 1179
2024
Q1 		$2.78M Buy
541,449
+160,251
+42% +$988K 0.01% 606
2023
Q4 		$2.18M Sell
381,198
-126,202
-25% -$624K 0.01% 648
2023
Q3 		$2.43M Buy
+507,400
New +$3.15M 0.01% 558
2023
Q2 		– Sell
-233,783
Closed -$1.24M – 1104
2023
Q1 		$1.24M Buy
233,783
+22,606
+11% +$141K 0.01% 744
2022
Q4 		$1.33M Buy
211,177
+79,938
+61% +$711K 0.01% 685
2022
Q3 		$1.39M Buy
+131,239
New +$1.22M 0.01% 590

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rafferty Asset Management's CRBU Position: Q2 2024 in Review

Rafferty Asset Management sold out of Caribou Biosciences (CRBU) in Q2 2024, closing a stake of 541,449 shares — an estimated $2.78M sold.

Rafferty Asset Management first reported a position in CRBU in Q3 2022 and held it in 6 quarters. The position peaked at $2.78M in Q1 2024. 140 funds tracked by Wall St. Rank hold CRBU as of Q2 2024.

  • Rafferty Asset Management reported no remaining Caribou Biosciences position as of Q2 2024 after selling out during the quarter.
  • Rafferty Asset Management sold 541,449 Caribou Biosciences shares in Q2 2024, an estimated $2.78M.
  • Rafferty Asset Management first reported a position in Caribou Biosciences in Q3 2022 and held it in 6 quarters.
  • Rafferty Asset Management's Caribou Biosciences position peaked at $2.78M in Q1 2024.
  • 140 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2024.

Based on Rafferty Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.